» Articles » PMID: 12768234

Immunoparalysis As a Cause for Invasive Aspergillosis?

Overview
Specialty Critical Care
Date 2003 May 28
PMID 12768234
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aspergillus infections are among the most feared opportunistic infections in humans. These organisms are ubiquitous in nature; protection against infection is usually provided by anatomical barriers and by the immune system. Tissue invasion by Aspergillus is uncommon, occurring primarily in the setting of immunosuppression. The prognosis of invasive aspergillosis is very poor. Although it is widely recognised that critically ill patients in the Intensive Care Unit (ICU) are at risk for nosocomial infections, it is not generally appreciated that such patients may also be at risk for opportunistic infections usually seen only in immunocompromised patients. This might be explained by a biphasic immunological pattern during sepsis: an early hyperinflammatory phase followed by an anti-inflammatory response, leading to a hypo-inflammatory state, the so-called compensatory anti-inflammatory response syndrome (CARS or immunoparalysis). We describe four patients admitted to our ICU for various reasons, without a history of abnormal immune function, who developed invasive pulmonary aspergillosis. We hypothesise that the occurrence of these opportunistic infections in our patients may have been due to immunoparalysis, and that perhaps all ICU patients with sepsis and multiple organ dysfunction syndrome (MODS) may be at risk for opportunistic infections such as aspergillosis as a result of this syndrome. Physicians treating critically ill patients in the ICU should be aware of the CARS/immunoparalysis syndrome and its potential to cause opportunistic infections, even in patients with normal immune function prior to ICU admission.

Citing Articles

Invasive aspergillosis in critically ill patients with diabetes mellitus: a systematic review and meta-analysis.

Liu Y, Zhang Z, Zhou L, Lin T, Zhang R, Li M BMC Infect Dis. 2025; 25(1):141.

PMID: 39885384 PMC: 11783785. DOI: 10.1186/s12879-025-10560-y.


Fungal lung disease.

Jaggi T, Agarwal R, Tiew P, Shah A, Lydon E, Hage C Eur Respir J. 2024; 64(5).

PMID: 39362667 PMC: 11602666. DOI: 10.1183/13993003.00803-2024.


The Fragile Patient: Considerations in the Management of Invasive Mould Infections (IMIs) in India.

Kundu P, Gupta N, Sood N Cureus. 2023; 15(4):e38085.

PMID: 37252469 PMC: 10209389. DOI: 10.7759/cureus.38085.


Invasive Pulmonary Aspergillosis.

Ledoux M, Herbrecht R J Fungi (Basel). 2023; 9(2).

PMID: 36836246 PMC: 9962768. DOI: 10.3390/jof9020131.


Severe Influenza With Invasive Pulmonary Aspergillosis in Immunocompetent Hosts: A Retrospective Cohort Study.

Duan Y, Ou X, Chen Y, Liang B, Ou X Front Med (Lausanne). 2021; 7:602732.

PMID: 33537328 PMC: 7848171. DOI: 10.3389/fmed.2020.602732.


References
1.
Matsushima K, Oppenheim J . Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine. 1989; 1(1):2-13. DOI: 10.1016/1043-4666(89)91043-0. View

2.
Bone R . The pathogenesis of sepsis. Ann Intern Med. 1991; 115(6):457-69. DOI: 10.7326/0003-4819-115-6-457. View

3.
Oren I, Haddad N, Finkelstein R, Rowe J . Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol. 2001; 66(4):257-62. DOI: 10.1002/ajh.1054. View

4.
Pittet D, Huguenin T, Dharan S, DUCEL G, Thorens J, Auckenthaler R . Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996; 154(2 Pt 1):541-4. DOI: 10.1164/ajrccm.154.2.8756836. View

5.
Saral R . Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis. 1991; 13(3):487-92. DOI: 10.1093/clinids/13.3.487. View